NL-OMON20009已完成不适用
A non-controlled trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade®) in Exudative Age Related Macular Degeneration.
Erasmus Medisch CentrumDr. Molewaterplein 403015 GD Rotterdam&Oogziekenhuis RotterdamSchiedamse Vest 1803011 BH Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
van Hagen PM, Baarsma GS, van Bilsen CE, Kuijpers RW, van Laar JA, van der Ent M, van Daele PL, Veeger NJ, Vingerling JR, Missotten TO. A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade®) in exudative age-related macular degeneration. Acta Ophthalmol. 2014; Epub ahead of print Jun 22. PMID: 24953977
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Have the capacity to understand and sign an informed consent form;
- •2. Men and women > 60 years of age;
排除标准
- •1. Ophthalmic exclusion criteria:
- •a. Inability to visualize the fundus due to corneal or important lenticular opacities;
研究者
相似试验
已完成
不适用
A placebo-controlled trial of anti-TNFa chimeric monoclonal antibody (infliximab, remicade) in the modification of vascular disease markers in active rheumatoid arthritisMusculoskeletal DiseasesRheumatoid ArthritisISRCTN29665463Guy's & St Thomas' NHS Foundation Trust (UK)30
暂停
不适用
An Open Label Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade®) in the Treatment of Endogenous Uveitis or Vasculitis unresponsive to Standard Therapy.Patients with endogenous uveitis or vasculitis (e.g. sarcoidosis, intermediate uveitis, Behcet’s, idiopathic ocular vasculitis, birdshot and VKH/sympathetic ophthalmia).NL-OMON20017AMC Medical Research B.V., Prof. Dr. M.D. de Smet, Meibergdreef 9, 1105 AZ AMSTERDAM ZO, The Netherlands, +31 20 566 34 5949
进行中（未招募）
1 期
A Prospective Trial of Anti-TNF-a Chimeric Monoclonal Antibody (infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human ObesityEUCTR2005-000181-39-ATMed. Universitaetsklinik Graz, ao Univ. Professor Dr. med. Thomas C. Wascher18
已完成
3 期
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCrohn DiseaseNCT00269841Centocor, Inc.94
已完成
2 期
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's DiseaseCrohn DiseaseNCT00269854Centocor, Inc.108